Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 62 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

62 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Dec. 2, 2020 ORGO P 38,710 $5.26 $203,615 200,000 Direct +24.00% Acquired -74.7% (price as of 2026-10-02)
Nov. 17, 2020 ORGO P 42,726 $3.25 $138,860 161,290 Direct +36.04% Acquired -59.1% (price as of 2026-10-02)
Sept. 13, 2019 ORGO P 1,032 $6.07 $6,264 100,000 Direct +1.04% Acquired -78.1% (price as of 2026-10-02)
Sept. 12, 2019 ORGO P 3,958 $6.14 $24,302 98,968 Direct +4.17% Acquired -78.3% (price as of 2026-10-02)
Sept. 11, 2019 ORGO P 3,133 $5.80 $18,171 95,010 Direct +3.41% Acquired -77.1% (price as of 2026-10-02)
Sept. 10, 2019 ORGO P 8,877 $5.17 $45,894 91,877 Direct +10.70% Acquired -74.3% (price as of 2026-10-02)
Sept. 9, 2019 ORGO P 1,000 $4.95 $4,950 83,000 Direct +1.22% Acquired -73.1% (price as of 2026-10-02)
Sept. 4, 2019 ORGO P 32,000 $4.70 $150,400 82,000 Direct +64.00% Acquired -71.7% (price as of 2026-10-02)
Sept. 3, 2019 ORGO P 50,000 $4.31 $215,500 50,000 Direct · Acquired -69.1% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Dec. 10, 2018 ORGO Stock Option (Right to Buy) Common Stock (30,000) $7.04 Dec. 10, 2028 30,000 Acquired
Nov. 8, 2014 CRAI Restricted Stock Units Common Stock (1,157) · · 1,157 Disposed
Nov. 8, 2014 CRAI Restricted Stock Units Common Stock (934) · · 934 Disposed
Nov. 19, 2013 CRAI Restricted Stock Units Common Stock (4,865) · · 4,865 Acquired
Nov. 19, 2013 CRAI Nonqualified Stock Option (right to buy) Common Stock (9,730) $18.48 Nov. 19, 2020 9,730 Acquired
Nov. 14, 2013 CRAI Restricted Stock Units Common Stock (900) · · 900 Disposed
Nov. 8, 2013 CRAI Restricted Stock Units Common Stock (1,157) · · 1,157 Disposed
Nov. 8, 2013 CRAI Restricted Stock Units Common Stock (933) · · 933 Disposed
Nov. 14, 2012 CRAI Restricted Stock Units Common Stock (900) · · 900 Disposed
Nov. 8, 2012 CRAI Restricted Stock Units Common Stock (1,157) · · 1,157 Disposed
Nov. 8, 2012 CRAI Restricted Stock Units Common Stock (933) · · 933 Disposed
March 5, 2012 CRAI Restricted Stock Units Common Stock (3,471) · · 3,471 Acquired
Nov. 17, 2011 CRAI Restricted Stock Units Common Stock (933) · · 933 Disposed
Nov. 14, 2011 CRAI Restricted Stock Units Common Stock (3,600) · · 3,600 Acquired
Nov. 14, 2011 CRAI Nonqualified Stock Option (right to buy) Common Stock (7,200) $21.91 Nov. 14, 2018 7,200 Acquired
Nov. 8, 2010 CRAI Restricted Stock Units Common Stock (3,733) · · 3,733 Acquired
Nov. 8, 2010 CRAI Nonqualified stock options (right to buy) Common Stock (7,466) $21.43 Nov. 8, 2017 7,466 Acquired
Oct. 5, 2005 CRAI Nonqualified Stock Option (right to buy) Common Stock (15,284) $41.16 Oct. 5, 2015 15,284 Acquired
Oct. 5, 2005 CRAI Incentive Stock Option (right to buy) Common Stock (9,716) $41.16 Oct. 5, 2015 9,716 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
July 28, 2005 CRAI Common Stock 0 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2014 $425,000 · · · $320,000 · $30,995 $775,995
2013 $375,000 · $209,766 $75,604 $205,000 · $24,627 $889,997
2012 $375,000 · · · · · $28,561 $403,561

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.